New collaborative study aims to identify mutations to improve clinical management of

[News]

Mr. Peter Goodhand, President of The Ontario Institute for Cancer Research (OICR), today announced a new collaborative research study in partnership with Thermo Fisher Scientific and Queen's University to help bring more targeted diagnosis and treatment to breast cancer patients in the future.

More... (http://www.news-medical.net/news/20160818/New-collaborative-research-aims-to-identify-mutations-to-improve-clinical-management-of-breast-cancer.aspx)